Pillstats
Rx only · Tablet · Oral

Methylergonovine Maleate

Brands: Methergine · Methylergonovine Maleate

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6883
US makers7 labelers
Packages14
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.65$3.30$4.96$6.61Dec 2025Apr 2026Jul 2026
$4.433
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
7
Active US suppliers
43%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5051.0K1.5K2.0K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.8K
Rx · 2026 Q1
14K
Units dispensed
+13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Rising Pharma Holdings, Inc.unknown4SUPPLYING
Granules Pharmaceuticals Incunknown2SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
Volley Pharmaceuticals, LLCunknown2SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 16, 2026
    RECALLRecall (Class II): Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distribu…

    Subpotent Drug — Recalling firm: The Harvard Drug Group LLC — U.S. Nationwide.